Maze Therapeutics raised $115 million in a Series D financing co-led by Frazier Life Sciences and Deep Track Capital to advance clinical-stage programs and future pipeline.
Amount Raised
$115 Million
Round Type
Series D
San FranciscoBiotechnologyHealth CareScience And EngineeringInvestors
Description
Maze Therapeutics, a clinical-stage biopharmaceutical company, has completed a $115 million Series D financing. This funding will support the advancement of their lead programs, MZE829 and MZE782.
Quick answer
Maze Therapeutics raised $115 Million in a Series D round, dated December 3, 2024. Investors: Casdin Capital, Woodline Partners LP, Janus Henderson Investors, Matrix Capital Management, ARCH Venture Partners, Third Rock Ventures, Logos Capital and GV. Maze Therapeutics is based in San Francisco, California, United States.
- How much did Maze Therapeutics raise?
- Maze Therapeutics raised $115 Million in a Series D round on December 3, 2024.
- Who invested in Maze Therapeutics?
- Casdin Capital, Woodline Partners LP, Janus Henderson Investors, Matrix Capital Management, ARCH Venture Partners, Third Rock Ventures, Logos Capital and GV are named as investors in this round.
- What does Maze Therapeutics do?
- Maze Therapeutics is translating novel genetic insights into lifesaving medicines, through an approach that integrates human genetics and functional genomics.
- Where is Maze Therapeutics based and how big is it?
- Maze Therapeutics is based in San Francisco, California, United States. Fundz records about 144 employees.
- Who are the decision-makers at Maze Therapeutics?
- Fundz holds 2 contacts at Maze Therapeutics. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Science And Engineering and Biotechnology around the same time
Companies in the same sectors as Maze Therapeutics that raised within 45 days of this round, from Fundz verified event records.
- Electra Therapeutics raised $180M on December 18, 2024.
- Orthogon Therapeutics raised $5.2M (Funding Round) on December 10, 2024.
- Mythic Therapeutics raised $30M on December 9, 2024.
- MAIA Biotechnology raised $2.4M (Seed) on October 28, 2024.
- MAIA Biotechnology raised $2.4M (Seed) on October 28, 2024.
- Agomab raised $89M (Series D) on October 25, 2024.
Who to call at Maze Therapeutics, and when
A new round usually means Maze Therapeutics is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Maze Therapeutics raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Maze Therapeutics, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Maze Therapeutics. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Maze Therapeutics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Maze Therapeutics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.